IPXL, CLNO, NHPR, – Stocks In Action For Tuesday! – Stock-PR.com (Video
Stock-pr Newsletter
__ IPXL, Impax Laboratories, Inc.
About 50,000 Americans are diagnosed with Parkinsons disease each year, with more than half a million Americans affected at any given time.
Parkinsons disease is associated with a team of disorders called motor system disorders, which are the result of the losing of dopamine-producing brain cells. Some fundamental symptoms of Parkinsons Disease are generally tremor, or moving in hands, arms, legs, jaw, and face; hardness, or maybe tightness of the limbs and trunk; bradykinesia, or slowness of movement; and postural lack of stability, or reduced balance as well as co-ordination. Since these symptoms become more evident, patients may have challenges walking, talking, or performing many other very simple tasks.
IPXL is a technology-based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. IPXL markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, IPXL has developed marketing partnerships to fully leverage its technology platform.
IPXL`s branded pipeline is focused on developing products targeting significant unmet needs in the central nervous system market. Within the companys branded division IPXL is currently developing a product for Parkinsons disease (IPX066), a product for Restless Legs Syndrome (IPX159) and a product for Spasticity in patients with Multiple Sclerosis (IPX056) ** IPX066 Demonstrates Efficacy and Safety in ADVANCE-PD Phase III Study in Treatment of Advanced Parkinsons Disease **
IPXL reported statistically significant, positive, top-line results of the ADVANCE-Parkinsons Disease (PD) Phase III clinical study of the safety and efficacy of IPX066 versus immediate-release (IR) carbidopa-levodopa (CD-LD) in advanced PD patients experiencing motor fluctuations. IPX066 is an investigational extended release (ER) CD-LD product. The ADVANCE-PD results demonstrated that IPX066 produced significantly improved control of motor symptoms as compared to IR CD-LD in multiple clinical measures in subjects with advanced PD.
The primary endpoint of this comparison study of IPX066 to IR CD-LD was the percentage of off time during waking hours. IPX066 demonstrated a 37% improvement from baseline for IPX066 vs. a 17% improvement from baseline for IR CD-LD (p<0.0001).
Off time is the functional state when patients medication effect has worn off and there is a return of Parkinsons symptoms.
IPXL plans to present complete results of the ADVANCE-PD study at an upcoming scientific meeting.
More about IPXL at www.impaxlabs.com.
******************
CLNO, Cleantech Transit, Inc., CLNO.OB CLNO was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. CLNO has expanded its focus to invest directly in specific green projects that can maximize shareholder value.
Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, CLNO has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project can generate shareholder returns as well benefit CLNO`s manufacturing clients worldwide.
Biomass renewable organic material such as wood and agricultural residues comprises the oldest and most prevalent energy resource. Even today, biomass is the worlds most popular fuel for heating.
With rising fossil fuel prices and growing environmental concerns, biomass energy systems are reclaiming their positions in schools, factories, military bases, and community energy plants.
CLNO recently reported the commencement of the final permitting prior to be able to go online at Merced. The Merced project is a 500 Kilowatt biomass-generated power plant that is fully constructed, owned and operated by Phoenix Energy.
The Merced project received permission for parallel testing to the grid. This testing process will allow Merced to connect to the grid on its own.
The plant is the first-of-its kind to receive an Authority to Construct permit from the San Joaquin Air Pollution Control District in California`s Central Valley as well as a use permit from Merced County.
According to CLNO, full scale commercial operation of the plant is expected to be completed during the second quarter of 2011. Once the interconnection process is complete, the 500 Kilowatt plant can begin selling power to one of California`s largest utilities under a fixed price 15-year contract. This positions CLNO to capitalize on numerous government incentives, including carbon credits, as well as help accelerate the adoption of renewable energies in the State of California.
Furthermore, the 500 Kilowatt plant should be eligible to apply for a renewable energy cash back incentive program offered by the U.S. Federal Government. If it concludes its planned investment in Phoenix Energy, under Section 1603 of the American Reinvestment and Recovery Act, CLNO will be entitled to receive its pro-rata share of 30% cash grant payments.
Once the final interconnect process and application are complete the grant should be received within 60 days.
More about CLNO at www.cleantechtransitinc.com.
******************
NHPR, National Health Partners, Inc., NHPR.OB NHPR is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.” CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. NHPR`s primary target customer group is the 47 million Americans who have no health insurance of any kind. NHPR`s secondary target customer group includes the millions of Americans who lack complete health insurance coverage.
NHPR reported the launch of a new network marketing program by one of its strategic partners, Xpress Healthcare, LLC.
Xpress Healthcare has teamed up with CARExpress in an effort to revolutionize the discount healthcare industry while at the same time bringing financial freedom to families across the nation. Xpress Healthcare has developed a first-class business platform that will enable brokers to develop their own business while generating strong monthly cash flows. Thru their unique website, www.join.xpressabo.com, brokers will be able to rapidly build their own independence.
By combining a first-rate platform for supporting a fast growing network of brokers with top notch individuals to head up their sales and training programs, Xpress Healthcare is now poised for significant growth. Xpress Healthcare is headed by two very talented individuals, Ed Pettola and Dan Gambardello, who have worked diligently to create a very strong corporate infrastructure for their broker network. The company has added a lot of depth to their management team including two individuals who have participated in the Million Dollar Round Table, a prestigious position in the insurance marketplace.
By the end of the second quarter of 2011, Xpress Healthcare anticipates adding over 100 new brokers both participating in and promoting NHPRs CARExpress program and should enroll over 2,500 new members. The company also expects its growth to accelerate in the 3rd quarter as it anticipates recruiting an additional 200 new brokers which should generate over 10,000 new CARExpress sales.
According to NHPR, offering tremendous growth potential, Xpress Healthcare is well positioned to become the leading marketing arm for its CARExpress and now Strong Sales are projected for 2nd Quarter from this new strategic partnership.
More about NHPR at www.nationalhealthpartners.com THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) anticipates receiving 2,000,000 shares of 144 restricted stocks from the company for 12 months of advertisement services for Cleantech Transit, Inc. (CLNO.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and anticipates receiving 3,000,000 shares of free trading shares from a third party for six months of advertisement services for National Health Partners Inc. (NHPR.OB).
— The following information is a reminder of your current mailing list subscription:
You are subscribed to the following list:
Stock-pr.com
Related posts:
- IPXL, CLNO, NHPR, – Stocks In Action For Tuesday! – Stock-PR.com (Video
- IPXL, CLNO, NHPR, – Morning Stocks To Watch! – CRWESelect.com (Video
- IPXL, CLNO, NHPR, – Morning Stocks To Watch! – StockHotTips.com (Video
- IPXL, CLNO, NHPR, – Morning Stock Watch! – DoubleInStocks.com (Video
- Impax Laboratories, Cleantech Transit, National Health Partners, – Stocks In